Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy

Woo-In Yang1, Chi Young Shim, Young Jin Kim

  • 1Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea.

Insights

Left atrial volume index predicts adverse outcomes in hypertrophic cardiomyopathy (HCM) patients, including heart failure hospitalizations and stroke. This key metric offers valuable prognostic information for managing HCM risks.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Heart Failure Research

Background:

  • Hypertrophic cardiomyopathy (HCM) can lead to sudden cardiac death and heart failure (HF).
  • Predicting adverse outcomes in HCM is crucial for patient management.
  • Identifying reliable prognostic markers in HCM is an ongoing clinical need.

Purpose of the Study:

  • To identify predictive parameters for adverse outcomes in nonapical hypertrophic cardiomyopathy (HCM).
  • To evaluate echocardiographic, cardiac magnetic resonance (CMR), and clinical markers for risk stratification.
  • To determine the prognostic value of left atrial (LA) volume index in HCM.

Main Methods:

  • Prospective evaluation of 81 nonapical HCM patients (51 male, mean age 57 years).
  • Patients underwent cardiac magnetic resonance (CMR) and echocardiography.
  • Cardiovascular events included HF hospitalization, stroke, or cardiovascular death over a mean follow-up of 41 months.

Main Results:

  • Seventeen cardiovascular events occurred during follow-up.
  • Univariate analysis identified age, atrial fibrillation, E/E' ratio, LA volume index, mitral regurgitation, NYHA class, and late gadolinium enhancement as associated with events.
  • Multivariate analysis revealed increased LA volume index as an independent predictor of cardiovascular events (HR 1.28 per 5 mL/m(2) increase) and non-death events (HR 1.44 per 5 mL/m(2) increase).

Conclusions:

  • Left atrial (LA) volume index is an independent predictor of adverse outcomes in hypertrophic cardiomyopathy (HCM).
  • LA volume index provides significant additional prognostic information for HCM patients.
  • This finding aids in risk stratification and management of patients with HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...